VRNA logo

Verona Pharma (VRNA) Net Income

Annual Net Income

-$54.37 M
+$14.33 M+20.86%

December 31, 2023

Summary

Performance

1-Year Change

+20.86%

3-Year Change

+16.54%

5-Year Change

-115.3%

15-Year Change

-96.28%

VRNA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.74%
VRNA annual net profit is higher than 35.74% of companies in Healthcare sector

High & Low

All-time High

$44.70 K
VRNA annual net profit is currently <-9900.00% below its historical high of $44.70 thousand

3-Year Low

-$68.70 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
VRNA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
VRNA next annual earnings announcement is scheduled for Feb 28, 2025

OtherVRNAprofitabilitymetrics:

Annual Net Margin

-
VRNA annual net profit margin value is unknown

Annual Revenue

-
VRNA annual revenue value is unknown

Annual Gross Profit

$0.00
VRNA annual gross profit is $0.00

Annual EPS

-$0.72
VRNA annual earnings per share is -$0.72

Quarterly Net Income

-$42.96 M
+$27.87 M+39.35%

September 30, 2024

Summary

Performance

3-Month Change

+39.35%

1-Year Change

+39.35%

3-Year Change

-488.76%

5-Year Change

-244.25%

VRNA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

11.69%
VRNA quarterly net profit is higher than 11.69% of companies in Healthcare sector

High & Low

All-time High

$11.05 M
VRNA quarterly net profit is currently -488.76% below its historical high of $11.05 million

3-Year Low

-$70.83 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VRNA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VRNA next earnings announcement is scheduled for Feb 28, 2025

OtherVRNAprofitabilitymetrics:

Quarterly Net Margin

-763.90%
VRNA quarterly net profit margin is -763.90%

Quarterly Revenue

$5.62 M
VRNA quarterly revenue is $5.62 million

Quarterly Gross Profit

$5.08 M
VRNA quarterly gross profit is $5.08 million

Quarterly EPS

-$0.56
VRNA quarterly earnings per share is -$0.56

TTM Net Income

-$153.72 M
-$28.27 M-22.54%

September 30, 2024

Summary

Performance

3-Month Change

-22.54%

1-Year Change

-22.54%

3-Year Change

-169.07%

5-Year Change

-280.09%

VRNA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

13.63%
VRNA TTM net profit is higher than 13.63% of companies in Healthcare sector

High & Low

All-time High

-$1.09 M

3-Year Low

-$153.72 M
VRNA TTM net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
VRNA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
VRNA next earnings announcement is scheduled for Feb 28, 2025

OtherVRNAprofitabilitymetrics:

Annual Net Margin

-
VRNA annual net profit margin value is unknown

TTM Revenue

$5.62 M
VRNA TTM revenue is $5.62 million

TTM Gross Profit

$5.08 M
VRNA TTM gross profit is $5.08 million

TTM EPS

-$2.00
VRNA TTM earnings per share is -$2.00

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$54.37 M
VRNA annual net profit is -$54.37 million

Annual Revenue

-
VRNA annual revenue value is unknown

Annual Cost Of Goods Sold

-
VRNA annual cost of goods sold value is unknown

Annual Operating Expenses

$66.47 M
VRNA annual total operating expenses is $66.47 million

Annual Interest Expense

$2.06 M
VRNA annual interest expense is $2.06 million

Annual Income Tax

$474.00 K
VRNA annual income tax is $474.00 thousand

VRNA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+20.9%+39.4%-22.5%
3 y3 years+16.5%-488.8%-169.1%
5 y5 years-115.3%-244.3%-280.1%

VRNA Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+20.9%-387.8%+39.4%-203.3%at low
5 y5-year-34.0%+20.9%-488.8%+39.4%-280.1%at low
alltimeall time<-9999.0%+20.9%-488.8%+39.4%<-9999.0%at low

Verona Pharma Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$42.96 M(-39.3%)
-$153.72 M(+22.5%)
Jun 2024
-
-$70.83 M(+174.6%)
-$125.45 M(+97.8%)
Mar 2024
-
-$25.79 M(+82.5%)
-$63.42 M(+16.6%)
Dec 2023
-$54.37 M(-20.9%)
-$14.13 M(-3.8%)
-$54.37 M(+7.3%)
Sep 2023
-
-$14.69 M(+66.8%)
-$50.69 M(-1.9%)
Jun 2023
-
-$8.81 M(-47.4%)
-$51.65 M(-14.8%)
Mar 2023
-
-$16.74 M(+60.2%)
-$60.61 M(-11.8%)
Dec 2022
-$68.70 M(+23.6%)
-$10.45 M(-33.2%)
-$68.70 M(-15.7%)
Sep 2022
-
-$15.65 M(-11.9%)
-$81.51 M(+48.7%)
Jun 2022
-
-$17.77 M(-28.5%)
-$54.81 M(-7.3%)
Mar 2022
-
-$24.84 M(+6.8%)
-$59.12 M(+6.4%)
Dec 2021
-$55.57 M(-14.7%)
-$23.26 M(-310.5%)
-$55.57 M(-2.7%)
Sep 2021
-
$11.05 M(-150.1%)
-$57.13 M(-34.4%)
Jun 2021
-
-$22.07 M(+3.7%)
-$87.11 M(+17.6%)
Mar 2021
-
-$21.29 M(-14.2%)
-$74.08 M(+13.7%)
Dec 2020
-$65.15 M(+60.6%)
-$24.82 M(+31.1%)
-$65.14 M(+30.7%)
Sep 2020
-
-$18.93 M(+109.5%)
-$49.86 M(+14.9%)
Jun 2020
-
-$9.04 M(-26.8%)
-$43.41 M(-5.1%)
Mar 2020
-
-$12.35 M(+29.4%)
-$45.74 M(+13.1%)
Dec 2019
-$40.56 M
-$9.54 M(-23.5%)
-$40.44 M(+18.7%)
Sep 2019
-
-$12.48 M(+9.8%)
-$34.07 M(+38.3%)
Jun 2019
-
-$11.37 M(+61.3%)
-$24.64 M(+97.6%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$7.05 M(+122.7%)
-$12.47 M(-53.4%)
Dec 2018
-$25.25 M(-8.8%)
-$3.17 M(+3.8%)
-$26.75 M(-17.0%)
Sep 2018
-
-$3.05 M(-481.7%)
-$32.22 M(-22.1%)
Jun 2018
-
$798.80 K(-103.7%)
-$41.38 M(-10.7%)
Mar 2018
-
-$21.34 M(+147.0%)
-$46.35 M(+69.1%)
Dec 2017
-$27.70 M(+347.3%)
-$8.64 M(-29.2%)
-$27.40 M(+41.0%)
Sep 2017
-
-$12.21 M(+193.3%)
-$19.43 M(+86.3%)
Jun 2017
-
-$4.16 M(+74.3%)
-$10.43 M(+41.8%)
Mar 2017
-
-$2.39 M(+255.4%)
-$7.36 M(+48.0%)
Dec 2016
-$6.19 M(-44.2%)
-$672.00 K(-79.0%)
-$4.97 M(+15.6%)
Sep 2016
-
-$3.21 M(+194.0%)
-$4.30 M(+294.0%)
Jun 2016
-
-$1.09 M
-$1.09 M
Dec 2015
-$11.10 M(+158.6%)
-
-
Dec 2014
-$4.29 M(+3.1%)
-
-
Dec 2013
-$4.16 M(+2.4%)
-
-
Dec 2012
-$4.07 M(+52.3%)
-
-
Dec 2011
-$2.67 M(-8.6%)
-
-
Dec 2010
-$2.92 M(+13.0%)
-
-
Dec 2009
-$2.59 M(+28.8%)
-
-
Dec 2008
-$2.01 M(-16.8%)
-
-
Dec 2007
-$2.41 M(+102.6%)
-
-
Dec 2006
-$1.19 M(-2764.9%)
-
-
Dec 2005
$44.70 K
-
-

FAQ

  • What is Verona Pharma annual net profit?
  • What is the all time high annual net income for Verona Pharma?
  • What is Verona Pharma annual net income year-on-year change?
  • What is Verona Pharma quarterly net profit?
  • What is the all time high quarterly net income for Verona Pharma?
  • What is Verona Pharma quarterly net income year-on-year change?
  • What is Verona Pharma TTM net profit?
  • What is the all time high TTM net income for Verona Pharma?
  • What is Verona Pharma TTM net income year-on-year change?

What is Verona Pharma annual net profit?

The current annual net income of VRNA is -$54.37 M

What is the all time high annual net income for Verona Pharma?

Verona Pharma all-time high annual net profit is $44.70 K

What is Verona Pharma annual net income year-on-year change?

Over the past year, VRNA annual net profit has changed by +$14.33 M (+20.86%)

What is Verona Pharma quarterly net profit?

The current quarterly net income of VRNA is -$42.96 M

What is the all time high quarterly net income for Verona Pharma?

Verona Pharma all-time high quarterly net profit is $11.05 M

What is Verona Pharma quarterly net income year-on-year change?

Over the past year, VRNA quarterly net profit has changed by +$27.87 M (+39.35%)

What is Verona Pharma TTM net profit?

The current TTM net income of VRNA is -$153.72 M

What is the all time high TTM net income for Verona Pharma?

Verona Pharma all-time high TTM net profit is -$1.09 M

What is Verona Pharma TTM net income year-on-year change?

Over the past year, VRNA TTM net profit has changed by -$28.27 M (-22.54%)